1st - ASTONISHING: Did you know that the New England Journal of Medicine (NEJM), the (alleged) most prestigious medical journal, DOES NOT ANALYZE THE DATA of the studies they publish? (1/7)
This was admitted by its EDITOR IN CHIEF, Eric Rubin, in an email he sent me. After months holding our manuscript on proxalutamide) and knowing the results since the beginning), they rejected arbitrarily and were not able to provide an explanation. (2/7)
When I asked Eric Rubin, he said that THEY DIMPLY DON’T HAVE THE CAPACITY to ANALYZE THE DATA, as you all can see in the email sent in June 15th, 2021, in the print attached to this tweet. (3/7)
It means that the NEW ENGLAND publishes papers BASED ON CONVENIENT ($$$?) RESULTS, NOT ON SCIENTIFIC STANDARDS. (4/7)
Interestingly, while our results were “too good”, similar level of efficacy was promptly published by New England. Obviously, no raw data available. (5/7)
This is more that sufficient to CONSIDER PUBLISHED STUDIES NO LONGER BETTER THAN PREPRINTS, even (specially) when published in HIGHLY PRESTIGIOUS JOURNALS. (6/7)
After this, do you still believe in publications from the New England Journal of Medicine? I don’t. The traditional editorial process has failed. #whistleblower #editorialgate
@Covid19Critical @FillerGabriel @filipe_rafaeli @SeivwrightTrudy @PierreKory @P_McCulloughMD @schmittpaula @epimeme @WHO @Ellengyn @RobertKennedyJr @VacSafety @ZimermanRicardo @RMConservative @richardursomd @MdBreathe @TPUSA @Doctor_Iver @david_agape_ @DrMarcosFalcao
Dear all, let’s try to make this arrive to the people that may turn it into a scandal (that deserves to be!) and force profound changes in the current editorial system.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.